1. Home
  2. ALG vs ZYME Comparison

ALG vs ZYME Comparison

Compare ALG & ZYME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alamo Group Inc.

ALG

Alamo Group Inc.

HOLD

Current Price

$191.64

Market Cap

2.3B

Sector

Industrials

ML Signal

HOLD

Logo Zymeworks Inc.

ZYME

Zymeworks Inc.

HOLD

Current Price

$24.51

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALG
ZYME
Founded
1955
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.0B
IPO Year
1993
2017

Fundamental Metrics

Financial Performance
Metric
ALG
ZYME
Price
$191.64
$24.51
Analyst Decision
Buy
Strong Buy
Analyst Count
2
9
Target Price
$225.00
$32.75
AVG Volume (30 Days)
114.5K
869.1K
Earning Date
02-26-2026
03-04-2026
Dividend Yield
0.72%
N/A
EPS Growth
N/A
N/A
EPS
9.64
N/A
Revenue
$1,615,388,000.00
$134,481,000.00
Revenue This Year
$1.26
$64.28
Revenue Next Year
$5.09
$106.98
P/E Ratio
$19.59
N/A
Revenue Growth
N/A
116.21
52 Week Low
$156.30
$9.03
52 Week High
$233.29
$28.49

Technical Indicators

Market Signals
Indicator
ALG
ZYME
Relative Strength Index (RSI) 71.58 48.07
Support Level $181.47 $22.46
Resistance Level $189.18 $25.35
Average True Range (ATR) 4.77 1.18
MACD 1.58 -0.40
Stochastic Oscillator 92.99 43.26

Price Performance

Historical Comparison
ALG
ZYME

About ALG Alamo Group Inc.

Alamo Group Inc is engaged in the design, manufacture, and servicing of high-quality vegetation management and infrastructure maintenance equipment for governmental, industrial and agricultural use. Its products include tractor-mounted and self-propelled mowers, zero-turn mowers, agricultural implements, tree and branch chippers, forestry/wood recycling equipment, street and parking lot sweepers, leaf and debris collection equipment, truck mounted highway attenuator trucks, vacuum trucks, hydro-excavation equipment, telescopic boom excavators, and snow removal equipment. The company's reportable segments are Vegetation Management and Industrial Equipment. It generates a majority of revenue from Vegetation Management. Geographically, it generates the majority of revenue from United States.

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

Share on Social Networks: